SCHEMBL13698455

SCHEMBL13698455

COc1ccccc1N1CCN(CC2CC3C=CC2C3)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.64
TSHR P16473 1/20 0.64
DRD2 P14416 3/20 0.62
DRD4 P21917 1/20 0.62
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
ALDH1A1 P00352 3/20 0.53
MAPK1 P28482 1/20 0.52
ADRA2A P08913 1/20 0.52
ADRA2B P18089 1/20 0.52
ADRA2C P18825 1/20 0.52
ADRA1A P35348 1/20 0.52
DRD3 P35462 1/20 0.51
HTT P42858 1/20 0.51
HTR1A P08908 2/20 0.51
ADRA1D P25100 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
HTR2C P28335 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13698449 0.88 KDM4E (0.62) KDM4ETSHRDRD2DRD4MEN1
SCHEMBL13698484 0.86 KDM4E (0.53) KDM4ETSHRDRD2DRD4MEN1
SCHEMBL3973853 0.85 KDM4E (0.57) KDM4ETSHRDRD2DRD4MEN1
SCHEMBL13698515 0.85 KDM4E (0.60) KDM4ETSHRDRD2DRD4MEN1
SCHEMBL13698487 0.84 DRD2 (0.62) KDM4ETSHRDRD2DRD4MEN1
SCHEMBL13698491 0.84 KDM4E (0.69) KDM4ETSHRDRD2DRD4MEN1
SCHEMBL13698495 0.82 KDM4E (0.67) KDM4ETSHRDRD2DRD4MEN1
SCHEMBL3977661 0.82 KDM4E (0.71) KDM4ETSHRDRD2DRD4MEN1
SCHEMBL13698428 0.81 KDM4E (0.69) KDM4ETSHRDRD2DRD4MEN1
SCHEMBL13764660 0.81 KDM4E (0.52) KDM4ETSHRDRD2DRD4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239873-A1 Phenyl-piperazine derivatives as modulators of muscarinic receptors BLANCO MIGUEL GARCIA-GUZMAN 2009-09-24 US disclosed
US-20090239873-A1 Phenyl-piperazine derivatives as modulators of muscarinic receptors BLANCO MIGUEL GARCIA-GUZMAN 2009-09-24 US disclosed
US-7563795-B2 Phenyl-piperazine derivatives as modulators of muscarinic receptors VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-07-21 US disclosed
US-7563795-B2 Phenyl-piperazine derivatives as modulators of muscarinic receptors VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239873-A1 Phenyl-piperazine derivatives as modulators of muscarinic receptors CHRM3, CHRM5, CHRM2 KDM4E 2199/4885TSHR 98/4885DRD2 506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.